Ben Hsu Email

VP, Clinical Development . Sangamo Therapeutics

Brisbane, CA

Location

b***@sangamo.com

Primary Email

Current Roles

Employees:
436
Revenue:
$108.5M
About
Sangamo BioSciences (Nasdaq: SGMO) develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particular class of transcription factors known as zinc finger DNA-binding proteins, or ZFPs. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression, and consequently, cell function
Sangamo Therapeutics Address
7000 Marina Boulevard
Brisbane, CA
United States
Sangamo Therapeutics Email

Past Companies

Sangamo Therapeutics, Inc.VP, Clinical Development
UNITY BiotechnologyVP, General Medicine
Johnson & Johnson/ Janssen R&DSr Director, Clinical Research

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.